VERNON HILLS, Ill.--(BUSINESS WIRE)--Elorac, Inc. announced today that results from its patient-centered outcomes trial for scalp psoriasis will be presented at the 73rd Annual Meeting of the AAD in San Francisco, California. The presentation (Abstract #1039), Patient – Centered Outcomes Trial of Anthralin Microcrystalline Encapsulated Shampoo for Treatment of Scalp Psoriasis, will be on Sunday, March 22, at 12:50 PDT.
Help employers find you! Check out all the jobs and post your resume.
